10 employees
Royal Emerald Pharmaceuticals produces non-addictive alternate medicines for dilemmas of PTSD and other health consequences.
2020
$17M
from 1 investors over 1 rounds
Royal Emerald Pharmaceuticals raised $17M on March 8, 2022
Investors: Pelorus Equity Group Inc.